Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

New aspects of diagnosis and therapy of hepatocellular carcinoma

Abstract

Hepatocellular carcinoma is one of the major cancer killers. It affects patients with chronic liver disease who have established cirrhosis, and currently is the most frequent cause of death in these patients. The main risk factors for its development are hepatitis B and C virus infection, alcoholism and aflatoxin intake. If acquistion of risk factors is not prevented and cirrhosis is established, the sole option to improve survival is to detect the tumor at an early stage when effective therapy may be indicated. Early detection plans should be based on hepatic ultrasonography every 6 months, whereas determination of tumor markers is not efficient. Upon detection of a hepatic nodule, there is a need to establish unequivocal diagnosis, either through biopsy or through the application of non-invasive criteria based on the specific radiology appearance of the tumor: fast arterial uptake of contrast followed by venous washout. Effective treatment for liver cancer includes surgical resection, liver transplantation and percutaneous ablation. These options provide a high rate of complete responses and are assumed to improve survival that should exceed 50% at 5 years. If the tumor is diagnosed at an advanced stage, the sole option that improves survival is transarterial chemoembolization. Ongoing research should further advance the time at diagnosis and identify new and effective options targeting molecular pathways governing tumor progression.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  • Beaugrand M, N’Kontchou G, Seror O, Ganne N, Trinchet JC . (2005). Semin Liver Dis 25: 201–211.

  • Bismuth H, Chiche L, Adam R, Castaing D . (1993). Transplant Proc 25 (Part 2): 1066–1067.

  • Bolondi L . (2003). J Hepatol 39: 1076–1084.

  • Bosch FX, Ribes J, Diaz M, Cleries R . (2004). Gastroenterology 127 (Suppl 1): S5–S16.

  • Bruix J, Castells A, Bosch J, Feu F, Fuster J, Garcia-Pagan JC et al. (1996). Gastroenterology 111: 1018–1022.

  • Bruix J, Castells A, Montanya X, Calvet X, Bru C, Ayuso C et al. (1994). Hepatology 20: 643–650.

  • Bruix J, Fuster J, Llovet JM . (2003). Liver Transplant 9: 700–702.

  • Bruix J, Llovet JM . (2002). Hepatology 35: 519–524.

  • Bruix J, Sala M, Llovet JM . (2004). Gastroenterology 127 (Suppl 1): S179–S188.

  • Bruix J, Sherman M . (2005). Hepatology 42: 1208–1236.

  • Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK et al. (2001). J Hepatol 35: 421–430.

  • Burrel M, Llovet JM, Ayuso C, Iglesias C, Sala M, Miquel R et al. (2003). Hepatology 38: 1034–1042.

  • Capurro M, Wanless IR, Sherman M, Deboer G, Shi W, Miyoshi E et al. (2003). Gastroenterology 125: 89–97.

  • Di Stasi M, Buscarini L, Livraghi T, Giorgio A, Salmi A, de Sio I et al. (1997). Scand J Gastroenterol 32: 1168–1173.

  • Freeman RB, Wiesner RH, Edwards E, Harper A, Merion R, Wolfe R . (2004). Liver Transplant 10: 7–15.

  • Garcia-Retortillo M, Forns X, Llovet JM, Navasa M, Feliu A, Massaguer A et al. (2004). Hepatology 40: 699–707.

  • Giorgio A, Tarantino L, de Stefano G, Coppola C, Ferraioli G . (2005). AJR Am J Roentgenol 184: 207–211.

  • Gondolesi GE, Roayaie S, Munoz L, Kim-Schluger L, Schiano T, Fishbein TM et al. (2004). Ann Surg 239: 142–149.

  • Grieco A, Pompili M, Caminiti G, Miele L, Covino M, Alfei B et al. (2005). Gut 54: 411–418.

  • Grimaldi C, Bleiberg H, Gay F, Messner M, Rougier P, Kok TC et al. (1998). J Clin Oncol 16: 411–417.

  • Group d’Etude et de Traitement de Carcinome Hepatocellulaire (GRETCH) (2004). Hepatology 40: 1361–1369.

  • Imamura H, Matsuyama Y, Tanaka E, Ohkubo T, Hasegawa K, Miyagawa S et al. (2003). J Hepatol 38: 200–207.

  • Ishizuka H, Nakayama T, Matsuoka S, Gotoh I, Ogawa M, Suzuki K et al. (1999). Intern Med 38: 927–931.

  • Izuno K, Fujiyama S, Yamasaki K, Sato M, Sato T . (1995). Hepatogastroenterology 42: 387–393.

  • Jonas S, Bechstein WO, Steinmuller T, Herrmann M, Radke C, Berg T et al. (2001). Hepatology 33: 1080–1086.

  • Kawasaki S . (2002). Hepatogastroenterology 49: 53–55.

  • Koike Y, Shiratori Y, Sato S, Obi S, Teratani T, Imamura M et al. (2001). Cancer 91: 561–569.

  • Kumada T, Nakano S, Takeda I, Kiriyama S, Sone Y, Hayashi K et al. (1999). J Hepatol 30: 125–130.

  • Lau WY, Leung TW, Ho SK, Chan M, Machin D, Lau J et al. (1999). Lancet 353: 797–801.

  • Laupacis A, Feeny D, Detsky AS, Tugwell PX . (1992). Can Med Assoc J 146: 473–481.

  • Lencioni R, Cioni D, Crocetti L, Franchini C, Pina CD, Lera J et al. (2005). Radiology 234: 961–967.

  • Lencioni R, Cioni D, Della PC, Crocetti L, Bartolozzi C . (2005). Semin Liver Dis 25: 162–170.

  • Lencioni RA, Allgaier HP, Cioni D, Olschewski M, Deibert P, Crocetti L et al. (2003). Radiology 228: 235–240.

  • Lin SM, Lin CJ, Lin CC, Hsu CW, Chen YC . (2004). Gastroenterology 127: 1714–1723.

  • Livraghi T, Giorgio A, Marin G, Salmi A, de Sio I, Bolondi L et al. (1995). Radiology 197: 101–108.

  • Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Solbiati L, Gazelle GS . (1999). Radiology 210: 655–661.

  • Livraghi T, Solbiati L, Meloni MF, Gazelle GS, Halpern EF, Goldberg SN . (2003). Radiology 226: 441–451.

  • Llovet JM, Bru C, Bruix J . (1999a). Semin Liver Dis 19: 329–338.

  • Llovet JM, Bruix J . (2003). Hepatology 37: 429–442.

  • Llovet JM, Bruix J, Fuster J, Castells A, Garcia-Valdecasas JC, Grande L et al. (1998). Hepatology 27: 1572–1577.

  • Llovet JM, Burroughs A, Bruix J . (2003). Lancet 362: 1907–1917.

  • Llovet JM, Fuster J, Bruix J . (1999b). Hepatology 30: 1434–1440.

  • Llovet JM, Mas X, Aponte JJ, Fuster J, Navasa M, Christensen E et al. (2002a). Gut 50: 123–128.

  • Llovet JM, Real MI, Montanya X, Planas R, Coll S, Aponte AJ, et al., for the Barcelona-Clínic-Liver Cancer Group. (2002b). The Lancet 359: 1734–1739.

  • Llovet JM, Schwartz M, Mazzaferro V . (2005). Semin Liver Dis 25: 181–200.

  • Llovet JM, Vilana R, Bru C, Bianchi L, Salmeron JM, Boix L et al. (2001). Hepatology 33: 1124–1129.

  • Lo CM, Ngan H, Tso WK, Liu CL, Lam CM, Poon RT et al. (2002). Hepatology 35: 1164–1171.

  • Majno P, Giostra E, Morel P, Hadengue A, Mentha G . (2005). J Hepatol 42 (Suppl 1): S134–S143.

  • Marrero JA, Fontana RJ, Barrat A, Askari F, Conjeevaram HS, Su GL et al. (2005). Hepatology 41: 707–716.

  • Marrero JA, Lok AS . (2004). Gastroenterology 127 (Suppl 1): S113–S119.

  • Marrero JA, Su GL, Wei W, Emick D, Conjeevaram HS, Fontana RJ et al. (2003). Hepatology 37: 1114–1121.

  • Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F et al. (1996). N Engl J Med 334: 693–699.

  • Muto Y, Moriwaki H, Ninomiya M, Adachi S, Saito A, Takasaki KT . (1996). N Engl J Med 334: 1561–1567.

  • Naimark D, Naglie G, Detsky AS . (1994). J Gen Intern Med 9: 702–707.

  • Paradis V, Degos F, Dargere D, Pham N, Belghiti J, Degott C et al. (2005). Hepatology 41: 40–47.

  • Parkin DM, Bray F, Ferlay J, Pisani P . (2005). CA Cancer J Clin 55: 74–108.

  • Sala M, Forner A, Varela M, Bruix J . (2005). Semin Liver Dis 25: 171–180.

  • Sala M, Fuster J, Llovet JM, Navasa M, Sole M, Varela M et al. (2004a). Liver Transplant 10: 1294–1300.

  • Sala M, Llovet JM, Vilana R, Bianchi L, Sole M, Ayuso C et al. (2004b). Hepatology 40: 1352–1360.

  • Sharma P, Balan V, Hernandez JL, Harper AM, Edwards EB, Rodriguez-Luna H et al. (2004). Liver Transplant 10: 36–41.

  • Sherman M . (2001). J Hepatol 34: 603–605.

  • Shibata T, Iimuro Y, Yamamoto Y, Maetani Y, Ametani F, Itoh K et al. (2002). Radiology 223: 331–337.

  • Shiina S, Teratani T, Obi S, Sato S, Tateishi R, Fujishima T et al. (2005). Gastroenterology 129: 122–130.

  • Shiratori Y, Shiina S, Teratani T, Imamura M, Obi S, Sato S et al. (2003). Ann Intern Med 138: 299–306.

  • Steinmuller T, Pascher A, Sauer I, Theruvath T, Muller A, Settmacher U et al. (2002). Transplant Proc 34: 2263–2264.

  • Suehiro T, Sugimachi K, Matsumata T, Itasaka H, Taketomi A, Maeda T . (1994). Cancer 73: 2464–2471.

  • Takayama T, Makuuchi M, Hirohashi S, Sakamoto M, Yamamoto J, Shimada K et al. (1998). Hepatology 28: 1241–1246.

  • Takayama T, Sekine T, Makuuchi M, Yamasaki S, Kosuge T, Yamamoto J et al. (2000). Lancet 356: 802–807.

  • Tateishi R, Shiina S, Teratani T, Obi S, Sato S, Koike Y et al. (2005). Cancer 103: 1201–1209.

  • Todo S, Furukawa H . (2004). Ann Surg 240: 451–459.

  • Torzilli G, Makuuchi M, Inoue K, Takayama T, Sakamoto Y, Sugawara Y et al. (1999). Arch Surg 134: 984–992.

  • Trevisani F, D’Intino PE, Morselli-Labate AM, Mazzella G, Accogli E, Caraceni P et al. (2001). J Hepatol 34: 570–575.

  • Yuen MF, Poon RT, Lai CL, Fan ST, Lo CM, Wong KW et al. (2002). Hepatology 36: 687–691.

  • Zhang BH, Yang BH, Tang ZY . (2004). J Cancer Res Clin Oncol 130: 417–422.

Download references

Acknowledgements

This work was partially funded by grant from Instituto Sanitario Carlos III (FIS number PI05/0150 and C03/02).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J Bruix.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bruix, J., Hessheimer, A., Forner, A. et al. New aspects of diagnosis and therapy of hepatocellular carcinoma. Oncogene 25, 3848–3856 (2006). https://doi.org/10.1038/sj.onc.1209548

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1209548

Keywords

This article is cited by

Search

Quick links